Skip to content

Research on abnormal white discharge in Unani Medicine

A Randomized Comparative Study of Brinjasif Versus Clindamycin plus Clotrimazole Suppository in Cervicitis - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076828
Enrollment
60
Registered
2024-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri

Interventions

Intervention1: Brinjasif Achillea millefolium Linn : One Suppository prepared using aqueous extract obtained from 5g of crude Brinjasif is administered intravaginally at bed time for 14days. Control I

Sponsors

Government Unani Medical College & Hospital Bangalore-560079
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married women between the age group of 18 to 40yrs. Patients with any complaints such as abnormal vaginal discharge, low back ache, lower abdominal pain, dysuria, dyspareunia. Presence of more than 30 leucocytes or PMN per field in the endocervical secretions.

Exclusion criteria

Exclusion criteria: Patients with systemic illness and STD’s. Patients on OCP’s and IUCD. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Changes in microscopic findings.Timepoint: microscopic changes will be assessed at baseline and after completion of trial.

Secondary

MeasureTime frame
Changes in clinical findings( low backache, white discharge, dyspareunia, dysuria, lower abdominal pain)Timepoint: secondary outcome will be assessed on 0th Day, 7th to 10th Day,14th to 18thDay & 30th to 34th Day.

Countries

India

Contacts

Public ContactDr Aisha Anjum A

Government Unani Medical College and Hospital

dr.aanjuma@gmail.com8951592300

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026